8:22 AM
Leo Group India
| ||
| Par Pharmaceutical Sued by Horizon Over Generic Duexis Drug Bloomberg Par Pharmaceutical Cos. was sued for patent infringement by Horizon Pharma Inc. (HNP) over a generic version of the drug Duexis, used to treat arthritis. Horizon, based in Northbrook, Illinois, contends Par plans to market a copy of the drug before two ... See all stories on this topic » | ||
| UW professor researches beer molecule for pharmaceutical company Dailyuw Werner Kaminsky, a crystallographer and UW professor of chemistry, closely studied a molecule called humulones, which is found in bitter beers, and his results contradicted previous findings about the molecule. His findings were published in the ... See all stories on this topic » | ||
| UK pharmaceutical supplier heads to Arab Health Zawya (registration) (press release) UK medical supplier Philip Chapper & Company Ltd. is set to attend the Arab Health exhibition in Dubai to explore new business opportunities. Arab Health is a four-day exhibition for the international healthcare market, attracting more than 80,000 ... See all stories on this topic » | ||
| Man burned in acid spill at Franklin pharmaceutical facility Hunterdon County Democrat - NJ.com FRANKLIN — A man was hospitalized after receiving acid burns on his head and back after a spill at a pharmaceutical manufacturing facility. At about 2:48 p.m. Thursday, police responded to Apicore LLC at 49 Napoleon Court for a reported industrial ... See all stories on this topic » | ||
| BioMarin Pharmaceutical Inc. Reports Inducement Grants Under NASDAQ ... NASDAQ 18, 2013 (GLOBE NEWSWIRE) -- BioMarin Pharmaceutical Inc. (Nasdaq:BMRN) today announced that on January 15, 2013, the compensation committee of BioMarin's board of directors approved the grant to 47 employees of stock options to purchase ... See all stories on this topic » |
This once a day Google Alert is brought to you by Google.
Delete this alert.
Create another alert.
Manage your alerts.
0 comments:
Post a Comment